Search Results

May 9, 2025

Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis

66% of patients with scalp psoriasis and 77% with genital psoriasis treated with investigational icotrokinra achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to demonstrate a standout combination of significant skin clearance (IGA 0/1) and a favorable safety profile in a once daily pill

May 8, 2025